We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Atrium Medical Sees 483 for Inadequate Design Controls
Atrium Medical Sees 483 for Inadequate Design Controls
The FDA handed cardiac device manufacturer Atrium Medical a Form 483 after a July-August 2022 inspection of its facility in Merrimack, N.H., found inadequate design and process controls among other lapses described as repeated systemic deficiencies.